Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Senzime Joins the Anesthesia Patient Safety Foundation (APSF) as a member of the Corporate Advisory Counsel

NEWS: Uppsala, June 23, 2020. Senzime AB (publ) today announces that they have joined the Anesthesia Patient Safety Foundation (APSF) as a member of the APSF Corporate Advisory Counsel. At Senzime, our focus on improving patient safety is our top priority. The Anesthesia Patient Safety Foundation (APSF) has a mission to improve continually the safety of patients during anesthesia care by encouraging and conducting safety research and education; patient safety programs and campaigns; national and international exchange of information and ideas. The purpose of the Corporate Advisory

AR Packaging – the new unified brand name in packaging

ÅR Packaging group of companies is one of Europe’s leading manufacturers in the packaging sector with net sales of more than 900 million euros and factories in 13 countries. The company is now incorporating all of its brands under one new identity – AR Packaging.[By coordinating our brands customers will get increased accessability to our complete product range and offering The driving force for us is to become the markets preferred packaging solution partner by helping customers grow their businesses said CEO Harald Schulz]  AR Packaging has seen continuous growth while maintaining

Alligator Bioscience receives first patent approval for ATOR-1017

Lund, Sweden, June 23, 2020 – Alligator Bioscience (Nasdaq Stockholm: ATORX) announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. US 10,689,454 which covers compositions of matter directed to Alligator’s drug candidate ATOR-1017, its wholly owned 4-1BB antibody in clinical Phase I development for the treatment of metastasized cancer. This is the first granted US patent related to ATOR-1017 and its earliest expiry year is 2037. “ATOR-1017 is one of our lead clinical assets and I am pleased to get this formal confirmation of our long-term

Alfa Laval wins SEK 160 million natural gas order in the US

Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – has won an order to supply air cooler systems to a gas processing plant in the U.S. The order has a value of approximately SEK 160 million. It is booked in the Welded Heat Exchangers unit of the Energy Division, with delivery scheduled for 2021.The order comprises Alfa Laval Niagara air cooler systems which will be used in several different steps of the gas treatment process, including process gas condensing and process liquid cooling. “I am very pleased to announce this large order for our Niagara

Conference call interim report

Invitation to attend Vitrolife’s conference call regarding presentation of the interim report January – June 2020. The presentation will be held in English.Time: Monday 13 July, 2020 at 10.00 a.m. CET.  Registration can preferably be done 10-15 minutes before the conference start time on: Sweden dial in number: +46 (0)8 566 184 67International dial in number: +44 (0) 2071 928338Conference name: Vitrolife, conference ID: 9246328 Vitrolife participants:Thomas Axelsson, CEOMikael Engblom, CFOThe press release for Vitrolife’s interim report will be released at 8.00 CET on

Sectra wins enterprise imaging contract at Swiss healthcare provider

Linköping, Sweden – June 23, 2020 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has signed a ten-year enterprise imaging contract with St. Claraspital in Basel, Switzerland. In this initial step toward a unified strategy for all its imaging needs, St. Claraspital will store medical images and multimedia from all medical specialties in an enterprise imaging solution and use the radiology module for image review. This will reduce IT complexity, increase reading and reporting efficiency, and enable efficient collaboration across

Atrium Ljungberg is hosting a presentation of Q2 Report 2020 on 10 July at 10.00 CET

Atrium Ljungberg is hosting an online broadcast of the Q2 Report 2020 presentation at 10.00 CET on 10 July 2020. The Q2 report 2020 will be published at 7.30 CET on the same day.Equity analysts, investors, media and other stakeholders are invited to participate in the conference where CEO Annica Ånäs and CFO Martin Lindqvist will present the results for Q2 2020. The presentation will be held in English and can be watched online using the following link: https://tv.streamfabriken.com/en-atrium-ljungberg-q2-2020 After the broadcast, the presentation and written material can be accessed on

American Shipping Company ASA: Primary Insider Disclosure

The following primary insiders (or their related parties as described below) have, as part of the company’s incentive program, today committed to acquire shares in American Shipping Company ASA (the "Company" or "AMSC"): * Pål Lothe Magnussen, CEO, has acquired 20,000 shares in AMSC. Upon completion of such acquisition, Pål Lothe Magnussen will own, directly or indirectly, 85,000 shares in the Company, corresponding to 0.14% of the share capital and votes in the Company. * Morten Bakke, CFO, has through his wholly owned company MB Capital AS acquired 30,000 shares in AMSC. Upon

Flexion Mobile signs multi-title agreement with Oasis Games

Bleach Immortal Soul and One Punch Man Road to Hero 2.0 are included in the dealLONDON, 23rd of June, 2020 – Flexion Mobile Plc (Nasdaq: FLEXM), the Android games distribution company today announced that it has signed a multi-title agreement with Oasis Games Limited. The two titles included in the distribution agreement are Bleach Immortal Soul and One Punch Man Road to Hero 2.0. Both games are new and Bleach Immortal Soul has since launch in February ramped up its revenue quickly. Sensor Tower estimates its May revenue to USD 2 million in Google Play. One Punch Man Road to Hero 2.0 is

Pure Performance by KM7, the world’s most modern board machine

BillerudKorsnäs launches Pure Performance, a White Top Kraftliner that combines high strength, excellent printability and purity in one material. Pure Performance is a unique paper product that offer packaging material reduction thanks to its 3-ply construction.Pure Performance is one of the first products from the world´s most modern board machine KM7 at BillerudKorsnäs and has received great appreciation among customers within the corrugating industry. Pure Performance offers extraordinary strength thanks to a 3-ply construction with optimized fiber properties: · The top ply contains

Vicore Pharma expands recruitment base for the ATTRACT study

Gothenburg, June 23, 2020 – Vicore Pharma Holding AB (publ), a pharmaceutical company dedicated to developing innovative medicines for rare lung disorders, today announces that the ATTRACT VP01 (C21) COVID-19 study has been approved by the health authorities in India.In order to accelerate recruitment in the ATTRACT study, Vicore Pharma has performed a thorough review to assess feasibility in countries outside UK and has filed a clinical trial application in India that was approved in record time. “Speed is of the essence in COVID-19, and India still has a steady increase in the number of

SciBase installs Nevisense Systems at Advanced Dermatology and Cosmetic Surgery Group in Florida

The nation’s premier dermatology group begins rollout of Nevisense technology to examine patients with irregular moles suspicious of melanomaStockholm, Sweden and Maitland, Florida, — June 23, 2020 — SciBase Holding AB  (“SciBase”) [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today that it has installed the first two Nevisense Systems at Advanced Dermatology and Cosmetics Surgery (“ADCS”) — the nation’s premier dermatology group. The Nevisense systems are now operational at ADCS’ Windermere, Florida

Halton Group to strengthen its Executive Team

To enhance the implementation of its growth strategy and to improve the utilization of scale benefits in its operation, Halton Group announces two nominations in the group management, effective as of 1 September 2020.Halton Group’s current CFO Janne Pukkila will take on a new role as Director, Operational Excellence. In this task, he will focus on driving operational excellence improvements across Halton’s units, including promoting synergy benefits, operational efficiency and related common initiatives. In his new role, Janne Pukkila will continue to report to Group CEO Kai Konola.

Change in Zengun Group AB’s management

Anna-Carin Bjelkeby, CFO of Zengun Group AB (publ) is stepping down at her own request. She will remain in the role until 31 August. Stefan Lindh, who is currently employed at the Group as Financial Controller, has been appointed the new CFO. Stefan is one of the founders of Zengun and has previously been responsible for the company’s finances.  “Anna-Carin’s work is highly appreciated, her wealth of experience with financial reporting and financing as well as her experience of the stock exchange have contributed to Zengun Group’s strong and stable financial position. I would like to

Targovax announces collaboration to evaluate ONCOS-102 in combination with KEYTRUDA[®] in mesothelioma

· Targovax to collaborate in a randomized phase II trial investigating the combination  ONCOS-102, Keytruda and standard of care chemotherapy in first line malignant pleural mesothelioma Oslo, Norway, 23 June 2020 - Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing oncolytic viruses to target hard-to-treat solid tumors, today announces that it has entered into a collaborative agreement with Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the US and Canada) with the intent to initiate a randomized phase II trial to evaluate the combination of ONCOS-

Successful restart of A-ROSA River Cruises

A-ROSA resumes voyages across all rivers and extends its early-booking-discounts for 2021Rostock, 22 June 2020 – After a successful restart of its Douro sailings in Portugal, A-ROSA River Cruises recommenced its cruises on the Rhine river on 17 June 2020 and on the Danube on 20 June 2020. The resumption of A-ROSA’s French operation will take place on 11 July 2020. "We are delighted to be cruising again on Europe’s most beautiful rivers. Naturally, we eagerly awaited feedback from the first guests that we welcomed on board. We are thrilled that it was very positive. It paid off to

Asetek A/S Announces Transactions Carried Out Under the Current Share Buyback Programme in Accordance With the "Safe Harbour Method"

June 22, 2020 - On May 19, 2020, Asetek A/S launched a share buyback programme, as described in company announcement of May 19, 2020. According to the programme, Asetek A/S will in the period until September 30, 2020 buy back own shares up to a maximum value of USD 4.5 million and with a maximum of 1,038,082 shares. The share buyback programme will be implemented in accordance with Regulation (EU) no. 596/2014 of 16th April 2014 of the European Parliament and Council and Commission Delegated Regulation (EU) no. 2016/1052, also referred to as the Safe Harbour rules. Trading day

Scandion Oncology announces that one of its founders, Saniona, has reduced its shareholding to below 15% of the total share amount

Scandion Oncology A/S (“Scandion Oncology”) announces that Saniona has reduced its ownership stake in Scandion Oncology A/S to below 15%. Saniona, together with CEO Nils Brünner and CSO Jan Stenvang initially founded Scandion Oncology A/S in 2017. After the last capital raise in June 2019, Saniona owned approximately 18% of Scandion Oncology. Proceeds from sales of shares will be used to continue Saniona’s advancement of their pipeline, including mid/late-stage clinical trials with Tesomet.Nils Brünner, CEO of Scandion Oncology says: “We are very grateful for the constructive and valuable

The Nomination Committee proposes new election of Anna Tenstam as ordinary Board member of Peptonic Medical

Stockholm, June 22, 2020. - Peptonic Medical AB (publ) ("The Company" or "Peptonic") - today announces that the Nomination Committee proposes that Anna Tenstam be elected to the Board. Furthermore, Hans von Celsing, Leni Ekendahl and Marianne Östlund are re-elected as members with Hans von Celsing as chairman. Arne Ferstad has declined re-election. The meeting will be held on June 30 in Stockholm.The Nomination Committee proposes that the members receive SEK 75,000 in remuneration per year and that the Chairman receive SEK 150,000. The Nomination Committee has been appointed on the basis

New Swedish patent approval for Episurf Medical

The Swedish patent office PRV has announced its intention to grant another Swedish patent for Episurf Medical (NASDAQ: EPIS B). The patent, entitled “An implant for cartilage and/or bone repair”, is within the area of joint implant materials and implant features.  “This is a patent covering combinations of implant bulk and coating materials, to protect specific features of Episurf’s Episealer® technology. We are happy for this first approval of this patent family”, says Katarina Flodström, COO, Episurf Medical.     For more information, please contact: Pål Ryfors, CEO, Episurf

Stillfront publishes approved bond prospectus and applies for listing of bonds on Nasdaq Stockholm

Press release22 June, 2020Stillfront Group AB (publ) has today applied for listing of its SEK 1,000 million senior unsecured floating rate bonds due 2024 (ISIN:0012728830) on Nasdaq Stockholm's Corporate Bond List. The first day of trading on Nasdaq Stockholm is expected to be on Wednesday 24 June 2020. For the purpose of the listing of the bonds, the company has prepared a prospectus that has today been approved by and registered with the Swedish Financial Supervisory Authority (Sw. Finansinspektionen). The prospectus is available on Stillfront’s corporate website https://www.

RNB subsidiaries apply to extend company reorganisations

RNB Retail and Brands AB (publ) subsidiaries have today to the Stockholm District Court applied to extend their ongoing company reorganisations (Sw. företagsrekonstruktioner). In the same applications the Companies petitioned a deferral to, and including, July 1, 2020 to complete the applications. By that date at the latest, the companies will present settlement proposals to the creditors. With the applications the companies’ company reorganisations continue until a formal decision to extend has been made by the District Court.

EAB GROUP PLC: ACQUISITION OF OWN SHARES 22.06.2020

EAB GROUP PLC NOTIFICATION 22.06.2020 at 18:30 EAB GROUP PLC: ACQUISITION OF OWN SHARES 22.06.2020 Date 22.06.2020Exchange transaction BuyShare class EABAmount 1,170Average price/share 2.1600 EURHighest price/share 2.1600 EURLowest price/share 2.1600 EURTotal price 2,527.20 EUR The shares held by EAB Group Plc on 22.06.2020: EAB 25,997 On behalf of EAB Group Plc  Skandinaviska Enskilda Banken AB (Publ) Antti Salakka         Mikko Virtanen For more information, please

#20-215 Delisting of certain Derivatives from NGM

Certain derivatives will be delisted from NGM.For more details see attached files. For further information concerning this NGM notice please contact: Listing department on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

There are no items matching the current filter
There are no more items matching the current filter
Back to top